Coherus Biosciences's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Coherus Biosciences last closed at $1.07 (+5.94%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -1.3×. Its overall grade ranks 619 of 738 stocks in Healthcare.
About this company
Coherus Biosciences last closed at $1.07 (+5.94%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 619/738
Valuation grade C+
Related stocks
- AmgenCompetitor
바이오시밀러·항암제 분야에서 경쟁하는 대형 바이오기업
- PfizerCompetitor
바이오시밀러 및 면역·항암 치료제 시장에서 경쟁
- SandozCompetitor
글로벌 바이오시밀러 전문 기업으로 Coherus의 핵심 경쟁사
About Coherus Biosciences
- What technical signals does Coherus Biosciences (CHRS) have?
- Coherus Biosciences current technical signals: no active technical signal.
- Is Coherus Biosciences a cup-and-handle pattern?
- No. Coherus Biosciences has no valid Cup signal right now.
- What published figures are available for Coherus Biosciences?
- Market cap: $129.33M. Trailing 12 months PER: -1.3×. Latest quarter PBR: 2.72×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Coherus Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.